PURPOSE: The purpose of this study was to evaluate white matter (WM) abnormalities induced by WBRT. MATERIALS AND METHODS: Twenty-four patients (11 men and 13 women; age range 38-74 years, median 60 years) who survived for more than 1 year after completion of WBRT (radiation dose range 30-40 Gy, median 35 Gy) at our institution between January 2000 and June 2003 were followed up with magnetic resonance (MR) scans for 11-51 months (median 19 months). We evaluated WM changes attributable to WBRT as grade 0-6 and assessed possible contributing factors by statistical analysis. RESULTS: WM changes were found in 20 patients: Eight were assessed as grade 2, three as grade 3, and nine as grade 5. In total, 12 patients developed grade 3 or higher WM changes. Age (<60 vs > or =60 years), sex, radiation dose (< or =35 vs >35 Gy), chemotherapy (with CDDP vs without CDDP), biologically effective dose (< or =120 vs >120 Gy1), and head width (<16.3 vs > or =16.3 cm) were found not to be relevant to the incidence or severity of the WM changes. CONCLUSION: Long-term survivors who have under-gone WBRT may have a higher incidence of WM abnormalities.
PURPOSE: The purpose of this study was to evaluate white matter (WM) abnormalities induced by WBRT. MATERIALS AND METHODS: Twenty-four patients (11 men and 13 women; age range 38-74 years, median 60 years) who survived for more than 1 year after completion of WBRT (radiation dose range 30-40 Gy, median 35 Gy) at our institution between January 2000 and June 2003 were followed up with magnetic resonance (MR) scans for 11-51 months (median 19 months). We evaluated WM changes attributable to WBRT as grade 0-6 and assessed possible contributing factors by statistical analysis. RESULTS: WM changes were found in 20 patients: Eight were assessed as grade 2, three as grade 3, and nine as grade 5. In total, 12 patients developed grade 3 or higher WM changes. Age (<60 vs > or =60 years), sex, radiation dose (< or =35 vs >35 Gy), chemotherapy (with CDDP vs without CDDP), biologically effective dose (< or =120 vs >120 Gy1), and head width (<16.3 vs > or =16.3 cm) were found not to be relevant to the incidence or severity of the WM changes. CONCLUSION: Long-term survivors who have under-gone WBRT may have a higher incidence of WM abnormalities.
Authors: S Frytak; J N Shaw; B P O'Neill; R E Lee; R T Eagan; E G Shaw; R L Richardson; D T Coles; J R Jett Journal: Am J Clin Oncol Date: 1989-02 Impact factor: 2.339
Authors: Nicholas Szerlip; Charles Rutter; Nilam Ram; Susannah Yovino; Young Kwok; William Maggio; William F Regine Journal: J Neurooncol Date: 2010-08-20 Impact factor: 4.130
Authors: Or Cohen-Inbar; Patrick Melmer; Cheng-chia Lee; Zhiyuan Xu; David Schlesinger; Jason P Sheehan Journal: J Neurooncol Date: 2016-01 Impact factor: 4.130
Authors: Timothy B Stokes; Ajay Niranjan; Hideyuki Kano; Phillip A Choi; Douglas Kondziolka; L Dade Lunsford; Edward A Monaco Journal: J Neurooncol Date: 2014-12-02 Impact factor: 4.130
Authors: Lei Shi; M Constance Linville; Elizabeth Iversen; Doris P Molina; Jessie Yester; Kenneth T Wheeler; Michael E Robbins; Judy K Brunso-Bechtold Journal: J Neurol Sci Date: 2009-07-21 Impact factor: 3.181
Authors: David S Sabsevitz; Joseph A Bovi; Peter D Leo; Peter S Laviolette; Scott D Rand; Wade M Mueller; Christopher J Schultz Journal: J Neurooncol Date: 2013-06-30 Impact factor: 4.130